Back to library

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

GnRH Agonist · Hormonal

Leuprolide (Lupron)

GnRH agonist used for prostate cancer, endometriosis, and precocious puberty.

FDA-Approved

Plain-Language Label Highlights

Brand names: Lupron, Eligard, Fensolvi

What it's approved for

Advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty.

A depot injection that initially raises and then deeply lowers sex hormones (testosterone/estrogen) by shutting down the pituitary signal.

Common side effects
  • Hot flashes
  • Injection-site reactions
  • Bone pain (initial flare)
  • Fatigue
  • Mood changes
Serious risks to know
  • Initial testosterone/estrogen surge worsening symptoms
  • Bone density loss with long-term use
  • Cardiovascular and metabolic effects
  • QT prolongation
Who should avoid or use with extra caution
  • Pregnancy
  • Known hypersensitivity to GnRH analogs
  • Uncontrolled cardiac arrhythmia (caution)

Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.

Mechanism of Action

Synthetic nonapeptide GnRH agonist. Continuous administration desensitizes pituitary GnRH receptors, suppressing LH/FSH and downstream sex hormone production (medical castration).

Research Areas

Advanced prostate cancer
Endometriosis
Uterine fibroids
Central precocious puberty
Gender-affirming care

Common Research Protocols

Prostate cancer depot

7.5 mg IM monthly, or 22.5 mg every 3 months.

Precocious puberty

Pediatric weight-based depot dosing.

Protocols summarized for educational reference from published research. Not dosing guidance.

Cited Research

[1]NEJM·1984

Leuprolide in metastatic prostate cancer

Established equivalence to orchiectomy for androgen suppression.

Important Considerations

  • FDA-approved.
  • Initial testosterone flare; hot flashes, bone density loss with long-term use.

Explore more peptides

Educational Information Only — Not Medical Advice

All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.

Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.

Searching the library…

Ask the Library

Ask anything about peptides — answers come from our curated reference library with citations.

Find a pharmacy that carries Leuprolide (Lupron)

Leave your details and a vetted partner pharmacy will reach out with availability and pricing.